42% of patients achieved complete remission within three months and the median duration of response was 14.1 months, the company noted in its release. While Gilead’s Tecartus and Novartis’ Kymriah ...
Camlin Fine Sciences Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 1,916.65 Crore) operating in Chemicals sector. Camlin Fine Sciences Ltd. key ...
From the end of November Market data will no longer be displayed here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback